Skip to content

Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.

Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07602738
Acronym
Periodontology
Enrollment
27
Registered
2026-05-22
Start date
2024-07-01
Completion date
2026-04-01
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diode Laser Therapy, Liquorice Nanogel, Periodontal Disease

Keywords

Liquorice Nanogel, Diode Laser, Real time pcr, P.gingivalis, 16s gene

Brief summary

Evaluation of the effect of liquorice nanogel versus diode laser on periodontitis stage Ⅲ clinically and microbiologically by molecular analysis of porphyromonas gingivalis using real time PCR.

Detailed description

Quantitative analysis technique using real time pcr (polymerase chain reaction) was done to detect presence of porphyromonas gingivalis. Pocket depth (PD), Plaque index (PI), gingival index (GI) and Clinical attachment level (CAL) were measured before work and after 3 months postoperatively. Analysis was made from gingival crevicular fluid samples of the patients using gutta percha paper points.

Interventions

DRUGLiquorice Nanogel

Real Time pcr was chosen to detect 16s gene concentration for porphyromonas gingivalis bacteria that is specific for Periodontitis Stage 3.

DRUGdiode laser

Real time Pcr was used to detect gene concentration 16s specific for porphyromonas gingivalis

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Intervention model description

Patient had Periodontitis stage III with pocket depth ≥ 6mm; indicated for periodontal surgery or CAL ≥ 5mm , Patient agreed to the surgical procedure and clinical trial, Age ranged between 18-50 years old. No previous drug was taken affecting bone metabolism , No Smokers Pregnant women and women with menopause were excluded. Patients with psychological problems were excluded. Patients with abnormal habits were excluded . Patients with medical conditions as Diabetes or Hypertension were excluded.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Patient had Periodontitis stage III with pocket depth ≥ 6mm; indicated for periodontal surgery or CAL ≥ 5mm. 2. Patient agreed to the surgical procedure and clinical trial. 3. Age ranged between 18-50 years old.

Exclusion criteria

* 1: No previous drug was taken affecting bone metabolism. 2- Smoking. 3- Pregnant women and women with menopause. 4- Patients with psychological problems . 5- Patients with abnormal habits. 6- Patients with medical conditions as Diabetes or Hypertension.

Design outcomes

Primary

MeasureTime frame
Quantitative analysis using real time pcr3 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026